Mariah Hanley, who grew up in Spokane Valley, learned early that her chances to lead a long life were slim because of cystic fibrosis, a progressive and frequently fatal genetic disease of the body’s mucus glands. But a few months ago, a doctor told Hanley, now 26, that she should start planning for retirement. A new breakthrough drug is changing the dialogue for CF patients.